Harvard Bioscience (HBIO) Goodwill (2010 - 2026)

Harvard Bioscience (HBIO) has reported Goodwill for 17 consecutive years, with $9.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Goodwill fell 8.1% year-over-year to $9.3 million in Q2 2026; TTM through Jun 2026 was $9.3 million, a 8.1% decrease from a year earlier, with the FY2025 full-year figure at $9.6 million, down 83.03% from the prior year.
• Goodwill was $9.3 million for Q2 2026 at Harvard Bioscience, roughly flat from $9.4 million in the prior quarter.
• Over five years, Goodwill peaked at $57.4 million in Q3 2024 and troughed at $9.0 million in Q1 2025.
• A 5-year average of $40.9 million and a median of $56.2 million in 2022 frame the typical range for Goodwill.
• Across the five-year window, Goodwill slumped 84.2% in 2025 and advanced 4.6% in 2026, its largest moves.
• Over 5 years, Goodwill stood at $56.3 million in 2022, then rose by 1.43% to $57.1 million in 2023, then dropped by 1.3% to $56.3 million in 2024, then slumped by 83.03% to $9.6 million in 2025, then fell by 2.4% to $9.3 million in 2026.
• The last three Goodwill figures came in at $9.3 million (Q2 2026), $9.4 million (Q1 2026), and $9.6 million (Q4 2025), per Business Quant data.